Cargando…

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea

PURPOSE: The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/or locally recurrent, unresectable gastric cancer (MGC) in South Korea. MATERIALS AND METHODS: Thirty physicians reviewed charts of eligible patients to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Gebra Cuyun, Kaltenboeck, Anna, Ivanova, Jasmina, Liepa, Astra M., San Roman, Alexandra, Koh, Maria, Rajan, Narayan, Cheng, Rebecca, Birnbaum, Howard G., Kim, Jong Seok, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512370/
https://www.ncbi.nlm.nih.gov/pubmed/27618820
http://dx.doi.org/10.4143/crt.2016.001
_version_ 1783250474564059136
author Carter, Gebra Cuyun
Kaltenboeck, Anna
Ivanova, Jasmina
Liepa, Astra M.
San Roman, Alexandra
Koh, Maria
Rajan, Narayan
Cheng, Rebecca
Birnbaum, Howard G.
Kim, Jong Seok
Bang, Yung-Jue
author_facet Carter, Gebra Cuyun
Kaltenboeck, Anna
Ivanova, Jasmina
Liepa, Astra M.
San Roman, Alexandra
Koh, Maria
Rajan, Narayan
Cheng, Rebecca
Birnbaum, Howard G.
Kim, Jong Seok
Bang, Yung-Jue
author_sort Carter, Gebra Cuyun
collection PubMed
description PURPOSE: The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/or locally recurrent, unresectable gastric cancer (MGC) in South Korea. MATERIALS AND METHODS: Thirty physicians reviewed charts of eligible patients to collect de-identified data. Patients must have received platinum/fluoropyrimidine first-line therapy followed by second-line therapy or best supportive care, had no other primary cancer, and not participated in a clinical trial following MGC diagnosis. Data were summarized using descriptive statistics. Kaplan-Meier analysis was used to describe survival. RESULTS: Of 198 patients, 73.7% were male, 78.3% were diagnosed with MGC after age 55 (mean, 61.3 years), and 47.0% were current or former smokers. The majority of tumorswere located in the antrum/pylorus (51.5%). Metastatic sites most often occurred in the peritoneum (53.5%), lymph nodes (47.5%), and liver (38.9%). At diagnosis, the mean Charlson comorbidity indexwas 0.4 (standard deviation, 0.6). The most common comorbidities were chronic gastritis (22.7%) and cardiovascular disease (18.7%). Most patients (80.3%) received second-line treatment. Single-agent fluoropyrimidine was reported for 22.0% of patients, while 19.5% were treated with irinotecan and a fluoropyrimidine or platinum agent. The most common physician-reported symptoms during second-line treatment were nausea/vomiting (44.7%) and pain (11.3%), with antiemetics (44.7%), analgesics (36.5%), and nutritional support (11.3%) most often used as supportive care. Two-thirds of inpatient hospitalizations were for chemotherapy infusion. Outpatient hospitalization (31.6%) and visits to the oncologist (58.8%) were common among second-line patients. CONCLUSION: Most patients received second-line treatment, although regimens varied. Understanding MGC patient characteristics and treatment patterns in South Korea will help address unmet needs.
format Online
Article
Text
id pubmed-5512370
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-55123702017-08-11 Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea Carter, Gebra Cuyun Kaltenboeck, Anna Ivanova, Jasmina Liepa, Astra M. San Roman, Alexandra Koh, Maria Rajan, Narayan Cheng, Rebecca Birnbaum, Howard G. Kim, Jong Seok Bang, Yung-Jue Cancer Res Treat Original Article PURPOSE: The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/or locally recurrent, unresectable gastric cancer (MGC) in South Korea. MATERIALS AND METHODS: Thirty physicians reviewed charts of eligible patients to collect de-identified data. Patients must have received platinum/fluoropyrimidine first-line therapy followed by second-line therapy or best supportive care, had no other primary cancer, and not participated in a clinical trial following MGC diagnosis. Data were summarized using descriptive statistics. Kaplan-Meier analysis was used to describe survival. RESULTS: Of 198 patients, 73.7% were male, 78.3% were diagnosed with MGC after age 55 (mean, 61.3 years), and 47.0% were current or former smokers. The majority of tumorswere located in the antrum/pylorus (51.5%). Metastatic sites most often occurred in the peritoneum (53.5%), lymph nodes (47.5%), and liver (38.9%). At diagnosis, the mean Charlson comorbidity indexwas 0.4 (standard deviation, 0.6). The most common comorbidities were chronic gastritis (22.7%) and cardiovascular disease (18.7%). Most patients (80.3%) received second-line treatment. Single-agent fluoropyrimidine was reported for 22.0% of patients, while 19.5% were treated with irinotecan and a fluoropyrimidine or platinum agent. The most common physician-reported symptoms during second-line treatment were nausea/vomiting (44.7%) and pain (11.3%), with antiemetics (44.7%), analgesics (36.5%), and nutritional support (11.3%) most often used as supportive care. Two-thirds of inpatient hospitalizations were for chemotherapy infusion. Outpatient hospitalization (31.6%) and visits to the oncologist (58.8%) were common among second-line patients. CONCLUSION: Most patients received second-line treatment, although regimens varied. Understanding MGC patient characteristics and treatment patterns in South Korea will help address unmet needs. Korean Cancer Association 2017-07 2016-09-12 /pmc/articles/PMC5512370/ /pubmed/27618820 http://dx.doi.org/10.4143/crt.2016.001 Text en Copyright © 2017 by the Korean Cancer Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Carter, Gebra Cuyun
Kaltenboeck, Anna
Ivanova, Jasmina
Liepa, Astra M.
San Roman, Alexandra
Koh, Maria
Rajan, Narayan
Cheng, Rebecca
Birnbaum, Howard G.
Kim, Jong Seok
Bang, Yung-Jue
Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
title Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
title_full Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
title_fullStr Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
title_full_unstemmed Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
title_short Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
title_sort real-world treatment patterns among patients with advanced gastric cancer in south korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512370/
https://www.ncbi.nlm.nih.gov/pubmed/27618820
http://dx.doi.org/10.4143/crt.2016.001
work_keys_str_mv AT cartergebracuyun realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT kaltenboeckanna realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT ivanovajasmina realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT liepaastram realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT sanromanalexandra realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT kohmaria realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT rajannarayan realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT chengrebecca realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT birnbaumhowardg realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT kimjongseok realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea
AT bangyungjue realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea